Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Calling DR Howard, Dr Fine, Dr Howard!
Funny how you always leave out that they acquired at least 2 AI companies, and did an IPO with that dilution. Some dilution is needed to grow. But, alas, I guess anything can be spun to achieve a narrative.
BTW, look at the additions to the board. Lots of positives going on here.
Flipper,
Agreed. He is starting, but was in front of a senate panel, and outright lied that he never did ANY Gain of Function research.
The truth needs to come out, and he needs to go.
So, now that we have this, what is next for the ASM?
If there was nothing else, we could have saved this,no?
I would love him to be CEO of NWBO.
I do not think that will happen with Linda Powers in charge.
She likes to control things, and I don't see Perlmutter being #2.
I don't see any big name being #2 to Linda Powers, and I am not a LP basher.
Maybe Perlmutter wants to take it easy in retirement, or semi retirement, and he will like it at EIKON.
I think Perlmutter is out.
He has a new job as CEO....
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=163605985
The kiss of death is here again.
He always brings his shorting losers with him.
I'm in your buyout camp.
It is the best solution, especially for getting this to approval and the patients.
The kiss of death will be here shortly.
What everyone fails to realize is that this is a diagnostics company, and they have a novel cancer test called Hemescreen, which was developed in house. This is a huge market, and PRPO has partnered with ION Solutions, which is a division of AmeriscourceBergen, on the sale of this test.
https://www.precipiodx.com/investors/pr/2021/0120/Precipio%20Signs%20HemeScreen%20Deals%20with%20Two%20Leading%20Oncology%20Groups.html
Following the recent publication introducing HemeScreen to physician office laboratories (POLs) in ION’s Oncologists Magazine, the partnership with ION has the potential to continue to open doors to hundreds of independent community oncology practices nationwide, with a joint effort of both companies’ sales teams to introduce this patient-centric technology to those groups.
I agree.
All I did was supply the link.
Stay close to the candles, the stairs can be very treacherous!
They need to get rid of Lincoln Park.
No doubt TC....thanks.
This buyer has been accumulating patiently for weeks.
Cryoport Inc. CYRX
Whats that sign say?
No Bare Feet!
Neither of those guys are gonna work under LP. I am not an LP hater. I think she has done an incredible job keeping this afloat, but she likes to be in control. Time to let some experienced people take the reins and bring this incredible drug to market.
Maybe no BP if Perlmutter is hired as CEO.
Otherwise it will be years before this gets to full potential.
Maybe bring Dr. Duffy as well.
He/She has been this way since posting on Yahoo message boards before here. Very rarely a good word for NWBO.
I don't see how you can submit a BLA to the FDA with no one to manufacture the vaccine in North America. Didn't CRL mention a phase 3 trial when they bought Cognate? Do you really think paying $900 million is getting Cognate for a SONG? Too much wrong with yur thinking for me.
This buyer seemed to be awfully patient the last week or so.
Can we figure into that market cap after TLD, that this was only a Phase 1 trial?
Aren't LP and Toucan owners of Advent?
Maybe it is so there are no lawsuits that they paid too much to line LP's pockets, yada yada yada.
Also, as greenJack said, the money buys them more runway time to negotiate. What the hell do I know?
Potatoes they need for European approval....
I must confess, I am a member of that club also.
Whatever, I'll stick with Sojo.
You stick with whatever you want.
I've been here since 2013, and have bought boatloads between $.14 and $.30. I'm kinda happy with $1.45, and waiting to go much higher.
Say what you may, Sojo has made some pretty astute calls in the past and present. I will stick with him over your darts.
BSB,
I have to agree with this thinking.
I remember before they locked the data, it took FOREVER, and they kept mentioning they were in the process of doing a soft lock, because they had all the data, but if I remember correctly, they were waiting on the IDH mutation, which they would include when finished.
So, like you, I believe they had all the numbers to play with long before Oct. 5th.
I am also buying here.
Too many catalysts, AmerisourceBergen partnership, Hemescreen, IV Cell, and new board members and new Chairman, with a wealth of experience. Only 18 million shares outstanding. Seems like a gift.
If you believe you can power the world with wind and solar....you are living a pipe dream. We are the cleanest nation on the planet. Go after China and India, there you will make some progress.
And BTW, if you don't like oil, stop using it every day, and see what your life is like.
LOLOL...you and Klaus Schwab and Joe can Build Back Better.
You have no idea what they have in store for you.
And I use propane in Northern Michigan, and don't want to pay double the price for tree huggers.
Cherry,
Who got all the contributions from Wall Street?
Hint, it was the Big Guy.
The oil by rail is a payoff to Warren Buffet, as he owns Burlington/Santa Fe railroad, who ships all the oil.
The environmentalists want to shut down Line5, a pipeline from Canada to Michigan which delivers oil and liquids for 55% of the propane for heating homes in Northern Michigan. Wonder what that will do to the price of propane?
Seems to me the best way forward is to stop the silly lockdowns.
Interesting, Very Interesting.
Thank you.
Adam finally getting his due.....
https://insiderfinancial.com/reddit-rebellion-targeting-the-short-mafia-next/180939/
The final one to report should be Northwest Biotech (NASDAQ: NWBO) with their phase 3 Glioblastoma trial. They are in the same situation as CVM, the data is locked and they are waiting for the final trial results report which could come at any moment, but it is likely to come before the shareholder meeting in April. Positive results from any of these famous Feuerstein pans could mean the end of his career and him drifting off into the journalistic sunset.